IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1

CUSIP: 46333XAD0

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Debt / DBCV 2.250% 6/1
Market price (% of par)
129.85%
Total 13F principal
$309,737,002
Principal change
-$1,082,000
Total reported market value
$402,581,410
Number of holders
32
Value change
-$1,594,319
Number of buys
12
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 46333XAD0?
CUSIP 46333XAD0 identifies 46333XAD0 - IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 as of Q3 2018

As of 30 Sep 2018, IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 was held by 32 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $309,737,002 in principal (par value) of the bond. The largest 10 bondholders included CITADEL ADVISORS LLC, Linden Advisors LP, WOLVERINE ASSET MANAGEMENT LLC, UBS ASSET MANAGEMENT AMERICAS INC, CALAMOS ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, Davidson Kempner Capital Management LP, CNH PARTNERS LLC, CAPSTONE INVESTMENT ADVISORS, LLC, and OAKTREE CAPITAL MANAGEMENT LP. This page lists 32 institutional bondholders reporting positions for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.